Chief Executive Officer, Aushon BioSystems
Susan Vogt has more than thirty years of experience in the global life science research, pharmaceutical, biotech and clinical diagnostics markets and is currently the Chief Executive Officer of venture-backed Aushon BioSystems, a life science and diagnostics tools company enabling the discovery and use of protein biomarkers for the diagnosis and treatment of complex diseases. Prior to joining Aushon, Vogt led the turnaround of SeraCare Life Sciences as President and CEO. There she successfully re-listed the company on NASDAQ and returned the company to profitability. Previously, Vogt held numerous senior level positions at Millipore Corporation and served as Corporate Officer and President of the BioPharmaceutical Division.
Vogt has served on the board of directors and advisory boards of a number of private and publicly held companies, including UK-based TAP BioSystems and Belfast-based Andor Technologies. In addition, she currently serves as Chair of the Board of Trustees at The Cambridge School of Weston in Massachusetts. Vogt earned her Bachelor’s degree from Brown University and MBA from Boston University.
No entries were found.